SCHEMBL21614710

SCHEMBL21614710

FC(F)(F)c1cc(SCc2nc3cc(Cl)c(Cl)cc3[nH]2)ccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ NPC1 O15118 6/20 0.41
▸ RAB9A P51151 6/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ PDE10A Q9Y233 2/20 0.40
▸ CACNA1G O43497 2/20 0.40
▸ CACNA1H O95180 2/20 0.40
▸ TYMS P04818 2/20 0.39
▸ PRKAG1 P54619 2/20 0.39
▸ PRKAA2 P54646 2/20 0.39
▸ PRKAB1 Q9Y478 2/20 0.39
▸ PRKAA1 Q13131 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21611986 0.92 PDE10A (0.40) GAAHTTNPC1RAB9AKMT2A
SCHEMBL21611980 0.87 NPC1 (0.48) HTTNPC1RAB9AKMT2AMEN1
SCHEMBL21611996 0.87 PDE10A (0.40) NPC1RAB9AKMT2AMEN1POLB
SCHEMBL30579945 0.83 NPC1 (0.40) GAANPC1RAB9AKMT2AMEN1
SCHEMBL30579946 0.83 NPC1 (0.40) GAANPC1RAB9AKMT2AMEN1
SCHEMBL25399746 0.83 NPC1 (0.40) NPC1RAB9AKMT2AMEN1POLB
SCHEMBL30040677 0.83 NPC1 (0.40) NPC1RAB9AKMT2AMEN1POLB
SCHEMBL24027388 0.82 GAA (0.50) GAAHTTNPC1RAB9AKMT2A
SCHEMBL26260644 0.80 NPC1 (0.40) NPC1RAB9AKMT2AMEN1POLB
SCHEMBL21611999 0.80 NPC1 (0.38) NPC1RAB9AKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 GAA 3075/4885HTT 3291/4885NPC1 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback